Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 39.80$. Average daily volumn in 3 months 8.95M. Market cap 53.40B



Stock symbol : BSX. Exchange : NYSE. Currency : USD
Lastest price : 37.35$. Total volume : 1.89M. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Boston Scientific Corporation (BSX)
Last Price
37.35$
Change
0.08
Volume
1.89M

Previous Close37.27
Open37.22
Day Range37.08-37.65
Bid37.36 x 800
Ask37.38 x 900
Volume1.89M
Average Volume8.95M
Market Cap53.4B
Beta0.82
52 Week Range34.98-47.50
Trailing P/E70.48
Foward P/E18.58
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to Boston Scientific Corporation's financial reports the company's revenue in 2021 were 11.89B an decrease( +22.22%) over the years 2020 revenue that were of 9.91B. In 2021 the company's total earnings were 1.04B while total earnings in 2020 were -82M(-1319.51%).


Loading ...



Organization

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Market Cap:
53.40B
Revenue:
11.89B
Total Assets:
32.23B
Total Cash:
1.93B


News about "Boston Scientific Corporation"

boston-scientific-nysebsx-given-new-4300-price-target-at-canaccord-genuity-group-image

Boston Scientific (NYSE:BSX) Given New $43.00 Price Target at Canaccord Genuity Group

Source from : Defense World - 15 hours ago

Boston Scientific (NYSE:BSX โ€“ Get Rating) had its target price cut by stock analysts at Canaccord Genuity Group from $51.00 to $43.00 in a research note issued to investors on Wednesday, Benzinga ...See details»


Boston Scientific Corporation (BSX) Volatility Hits 2.12% โ€“ Hereโ€™s What An Investor Can Do

Source from : stocksregister - 1 days ago

Boston Scientific Corporation (NYSE:BSX) at last check was buoying at $37.10 on Thursday, June 30, with a fall of -1.85% from its closing price on previous day. Taking a look at stock we notice that ...See details»


boston-scientific-to-open-atlanta-plant-image

Boston Scientific to open Atlanta plant

Source from : The Business Journals - 1 days ago

Boston Scientificโ€™s new plant validates Atlanta's emerging life sciences industry and acts as a catalyst for a suburban town center project.See details»


as-a-triple-minority-shae-finally-feels-seen-at-boston-scientific-image

As a Triple Minority, Shae Finally Feels Seen at Boston Scientific

Source from : CSR Wire - 8 hours ago

Shae Wilson grew up in a military family, bouncing around from California to Japan, and then to North Carolina where her family finally settled and put down roots.See details»


boston-scientific-announces-conference-call-discussing-second-quarter-2022-results-image

Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results

Source from : YAHOO!Finance - 2 days ago

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ending June 30, 2022 on Wednesday, July 27, 2022 ...See details»


boston-scientific-to-open-atlanta-plant-latest-life-sciences-win-image

Boston Scientific to open Atlanta plant, latest life sciences win

Source from : The Business Journals - 2 days ago

Boston Scientificโ€™s new plant validates Atlanta's emerging life sciences industry and acts as a catalyst for a suburban town center project.See details»


state-of-alaska-department-of-revenue-cuts-stock-holdings-in-boston-scientific-co-nysebsx-image

State of Alaska Department of Revenue Cuts Stock Holdings in Boston Scientific Co. (NYSE:BSX)

Source from : ETF Daily News - 5 days ago

Boston Scientific Company Profile (Get Rating) Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It ...See details»


boston-scientific-to-purchase-majority-stake-of-mitech-image

Boston Scientific To Purchase Majority Stake of M.I.Tech

Source from : medtechintelligence - 9 days ago

M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.โ€ ...See details»


boston-scientific-remembers-cofounder-pete-nicholas-1941-2022-image

Boston Scientific Remembers Cofounder Pete Nicholas, 1941-2022

Source from : Endovascular Today - 11 days ago

In an extensive online tribute, Boston Scientific Corporation announced the death of Peter M. โ€œPeteโ€ Nicholas, the com ...See details»


Worldwide Surgical Clips Industry to 2027 - Featuring Ackermann Instruments, Boston Scientific and Johnson & Johnson Among Others

Source from : Yahoo Finance - 2 days ago

Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Grena Limited, Johnson & Johnson, LeMaitre Vascula Inc., LocaMed Ltd., Medtronic plc, Meril Life Sciences Pvt.See details»


New Suit - Product Liability

Source from : Law - 10 days ago

Counsel have not yet appeared for the defendant. The case is 6:22-cv-00976, McDermott v. Boston Scientific Corporation.See details»


tell-us-are-you-worried-about-spiked-drinks-at-boston-bars-image

Tell us: Are you worried about spiked drinks at Boston bars?

Source from : Boston.com - 7 hours ago

Are you concerned about going out in Greater Boston given the reports of spiked drinks? Tell us on Boston.com.See details»


Peripheral Guidewires Market Prognosticated For A Ravishing Growth By 2030 | Abbott Vascular, Boston Scientific Corporation, CONMED Corporation

Source from : Digital Journal - 7 days ago

New Jersey, United States-Peripheral Guidewires Market 2022 โ€“ 2030, Size, Share, and Trends Analysis Research Report Segmented with Type, Component, Application, Region, and Forecast Peripheral ...See details»


Spinal Stimulator Market Analysis In-depth Growth Projection with Regional Demand and Revenue Forecast Till 2028 |Boston Scientific Corp., Medtronic

Source from : Digital Journal - 10 days ago

The โ€œSpinal Stimulator Marketโ€ Report is an extensive study that focuses on overall consumption patterns, development trends, sales patterns, and sales in key countries of the Spinal ...See details»